NEW YORK (GenomeWeb News) – MDS today reported that its second-quarter 2008 revenues rose 24 percent, though only 5 percent excluding the impact of currency exchange and acquisitions.
 
The Toronto-based firm brought in revenues of $326 million for the three-month period ended April 30, compared to $263 million in the comparable period of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.